Farmak JSC increased its medicine sales by 18.35%
Farmak JSC increased sales of medicines by 18.35%
According to the results of Q1 2018, Farmak JSC increased its sales by 18.35% to 1.1 billion UAH against Q1 2017. Proxima Research data.
“For eight years straight now Farmak has been the leader on the pharmaceutical market of the country*. The company has achieved such results due to quality and innovation. Over the past seven years Farmak has spent 2.8 billion hryvnyas on the development and modernization of production. Today, all the equipment of the Company is high-tech and ultra-modern. Production lines meet GMP, ISO requirements. Farmak’s focus is the manufacture of innovative biotech products. These include Flenox, insulin and its analogues, X-ray contrast agents. At the same time, we continue to produce basic drugs that have been on the market for a few decades,” said Volodymyr Kostiuk, acting Executive Director of Farmak JSC.
The Executive Director of Farmak became a finalist in TOP 25 Best Managers rating compiled by TOP 100. Ratings of the Largest. Volodymyr Kostiuk was recognized as an effective manager in the Leaders of Change category. The award ceremony took place as part of the Business Wisdom Summit. Volodymyr Kostiuk has been the Executive Director […]
The book “Bude tobi nauka: ukrainski vcheni, yaki zminiuiut svit” (That’s science for you: Ukrainian scientists changing the world) and the corporate magazine Science inside won the Grand Prix of the competition “The Best Corporate Media of Ukraine 2020”. The competition experts also highly praised other projects of Farmak press service. The corp...
Farmak is the only pharmaceutical company included in the rating of “TOP 25 Innovative Companies of Ukraine” according to the magazine “Vlast Deneg” (The Power of Money) When determining the rating winners, the main criterion was not only the availability of innovative plans for the future, but also innovations already successfully implemented in manufacturi...